Ligand profile
2WU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02055 — Queuine tRNA-ribosyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
2WU- PDB
4puk- UniProt (similar protein)
P28720- Target protein
- KP13_02055
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 112.5
- −1 ≤ LogP ≤ 5 0.42
- MW ≤ 500 Da 230.2
- LogP ≤ 5 0.42
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 112.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CNc1[nH]c2cc3c(cc2n1)C(=O)NC(=N3)NCNc1[nH]c2cc3c(cc2n1)C(=O)NC(=N3)N
InChI=1S/C10H10N6O/c1-12-10-14-6-2-4-5(3-7(6)15-10)13-9(11)16-8(4)17/h2-3H,1H3,(H2,12,14,15)(H3,11,13,16,17)InChI=1S/C10H10N6O/c1-12-10-14-6-2-4-5(3-7(6)15-10)13-9(11)16-8(4)17/h2-3H,1H3,(H2,12,14,15)(H3,11,13,16,17)
MRAWGMPHZYODAJ-UHFFFAOYSA-NMRAWGMPHZYODAJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01702
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 2WU →
- PDB RCSB structure 4puk →
- UniProt UniProt P28720 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “2WU”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02055.
PDB 60
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).